Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

U.S. govt signs deal to make more COVID-19 vaccine components

10/13/2020 | 02:23pm EST

Oct 13 (Reuters) - The U.S. government has entered an agreement with Danaher Corp-owned Cytiva to expand the manufacturing of products that are essential for producing COVID-19 vaccines, the U.S. Department of Health and Human Services said on Tuesday.

Under the deal, Cytiva will receive about $31 million to scale up manufacturing of vaccine-related products. (Reporting By Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)


© Reuters 2020
All news about DANAHER CORPORATION
11/23DANAHER : Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antib..
PR
11/17DANAHER : to Present at Wolfe Research Healthcare Conference
AQ
11/16DANAHER : To Present At Wolfe Research Healthcare Conference
PR
11/11DANAHER : Releases 2020 Sustainability Report
AQ
11/10DANAHER : Releases 2020 Sustainability Report
PR
11/10DANAHER : Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries..
PR
10/27DANAHER : Cytiva strengthens support to diagnostics industry with new labs, serv..
AQ
10/23DANAHER : Reports Third Quarter 2020 Results
AQ
10/22DANAHER : 3Q Profit, Sales Rise
DJ
10/22DANAHER : 3Q Earnings Snapshot
AQ
More news
Financials (USD)
Sales 2020 21 957 M - -
Net income 2020 3 387 M - -
Net Debt 2020 15 370 M - -
P/E ratio 2020 47,3x
Yield 2020 0,32%
Capitalization 157 B 157 B -
EV / Sales 2020 7,85x
EV / Sales 2021 6,73x
Nbr of Employees 60 000
Free-Float 74,1%
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | MarketScreener
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 251,45 $
Last Close Price 221,08 $
Spread / Highest target 26,7%
Spread / Average Target 13,7%
Spread / Lowest Target -37,6%
EPS Revisions
Managers
NameTitle
Rainer M. Blair President, Chief Executive Officer & Director
Steven M. Rales Chairman
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Walter G. Lohr Independent Director
Sector and Competitors